The expression of YAP1 is increased in high-grade prostatic adenocarcinoma but is reduced in neuroendocrine prostate cancer

BACKGROUND: After long-term androgen deprivation therapy, 25–30% prostate cancer (PCa) acquires an aggressive neuroendocrine (NE) phenotype. Dysregulation of YAP1, a key transcription coactivator of the Hippo pathway, has been related to cancer progression. However, its role in neuroendocrine prosta...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Siyuan, Prieto-Dominguez, Nestor, Yang, Shu, Connelly, Zachary M., StPierre, Samantha, Rushing, Bryce, Watkins, Andy, Shi, Lawrence, Lakey, Meredith, Baiamonte, Lyndsey Buckner, Fazili, Tajammul, Lurie, Aubrey, Corey, Eva, Shi, Runhua, Yeh, Yunshin, Yu, Xiuping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572469/
https://www.ncbi.nlm.nih.gov/pubmed/32313141
http://dx.doi.org/10.1038/s41391-020-0229-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572469/
https://www.ncbi.nlm.nih.gov/pubmed/32313141
http://dx.doi.org/10.1038/s41391-020-0229-z

Ejemplares similares